Last reviewed · How we verify

NCT05809661: rct

Implementation of the Nurse Navigation Program

Completed Last updated 12 April 2023
What this trial tests

trial testing implementation of the nurse navigation program in Intestinal Cancer in 58 participants. Completed in 31 December 2021.

Timeline
1 January 2021
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorKilis 7 Aralik University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment58
Start date1 January 2021
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kilis 7 Aralik University

Who can join

18 and older, any sex, with Intestinal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted as a randomized controlled intervention study with repetitive measurements in a pretest-posttest order to examine the effect of nurse navigation program on compliance, quality of life and prevention of complications in patients with intestinal stoma. The study was completed with 30 experimental and 28 control group patients with intestinal stoma in six hospitals, two of which are training and research hospitals, located in Gaziantep city center, between January 1 and December 31, 2021. While counseling, remote support, written and visual trainings, informative messages, phone calls, and appointment scheduling were applied to the patients in the experimental group within the scope of the nurse navigation program, the patients in the control group received standard care

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kilis 7 Aralik University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05809661.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing